Advertisement
  • Q&A

    Taking the Long View

    In her first book, journalist and breast cancer survivor Kate Pickert traces the winding road of cancer research and patient advocacy.

    by Marci A. Landsmann

  • Keeping CLL in Check

    With recent advances in targeted treatments, people diagnosed with chronic lymphocytic leukemia have more options to manage the disease.

    by Kendall K. Morgan

  • Policy Matters

    Racial and Ethnic Disparities in Multiple Myeloma Clinical Trials

    The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

    by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

  • Healthy Habits

    Active Treatment

    Regular exercise may help mitigate the lingering psychological impact of childhood cancer.

    by Carisa D. Brewster

  • Robotic Surgery and Cancer

    Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.

    by Sue Rochman

  • Survivor Profile

    Sharing Her Strength

    Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

    by Lindsey Konkel

  • A Modern Family

    My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent.

    by Allison Rosen

  • Why Are Early-Onset Cancers Rising?

    Some cancers that are most commonly diagnosed in older adults are becoming increasingly prevalent in young adults.

    by Kate Yandell

  • Pediatric Oncologists Underestimate Needs of Minority Parents

    Research describes how communication gaps can shift extra burden to parents who are members of ethnic and racial minority groups.

    by Marci A. Landsmann

  • Why Skip a Dose?

    A survey of over 1,000 breast cancer patients prescribed endocrine therapy sheds light on low adherence.

    by Emma Yasinski